SCHEMBL7699367

SCHEMBL7699367

CCOC(=O)C(Cc1ccc2c(c1)OCO2)C(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.58
HSD17B10 Q99714 2/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 1/20 0.51
USP2 O75604 1/20 0.51
ALDH1A1 P00352 1/20 0.51
ALOX15 P16050 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP2D6 P10635 3/20 0.50
SLC6A4 P31645 3/20 0.50
TAAR1 Q96RJ0 2/20 0.50
HPGD P15428 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A3 Q01959 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157430 0.93 CYP3A4 (0.58) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL9585882 0.92 CYP3A4 (0.48) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL7574108 0.91 CYP3A4 (0.56) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL9126115 0.87 CYP3A4 (0.60) CYP3A4MAPTLMNAALDH1A1CYP2D6
SCHEMBL9263319 0.85 CYP3A4 (0.59) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL8248139 0.85 CYP3A4 (0.59) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL11000389 0.85 CYP3A4 (0.57) CYP3A4LMNAALDH1A1CYP2D6SLC6A4
Hydrochloric Acid SCHEMBL8497507 0.84 CYP3A4 (0.58) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL3572819 0.84 KMT2A (0.49) CYP3A4HSD17B10MAPTLMNAMEN1
SCHEMBL11732644 0.83 CYP3A4 (0.56) CYP3A4HSD17B10MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0180745-A1 Acylacetate and amidine intermediates for pyrimidone compounds, and their preparation YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1986-05-14 EP claimed
US-6348618-B1 PREPARING ORGANOLEPTIC OR ANTIMICROBIAL COMPOUNDS BY CONTACTING BETA-KETO ESTER WITH MATERIAL SELECTED FROM BACTERIA, ENZYMES, AND MATERIAL HAVING ACIDIC OR ALKALINE PH, ELEVATING TEMPERATURE, EXPOSING TO LIGHT GIVAUDAN ROURE (INTERNATIONAL) SA (CH) 2002-02-19 US disclosed
US-6222062-B1 USEFUL AS PRECURSORS FOR ORGANOLEPTIC COMPOUNDS, ESPECIALLY FOR FLAVORS, FRAGRANCES AND MASKING AGENTS AND ANTIMICROBIAL COMPOUNDS GIVAUDAN ROURE (INTERNATIONAL) SA (CH) 2001-04-24 US disclosed
EP-1090624-A2 Beta ketoester Givaudan SA (CH) 2001-04-11 EP disclosed
EP-0911315-A1 Beta-ketoester Givaudan Roure (International) S.A. (CH) 1999-04-28 EP disclosed